Pfizer pledges to sell all of its products at cost to poor countries

Pfizer has expanded its program to provide drugs at cost to the world’s poorest countries from 23 patented medicines to its entire suite of approximately 500 products.

The New York pharma giant first revealed its initiative, dubbed “An Accord for a Healthier World,” last May. At the time, the program included Pfizer's COVID-19 oral antiviral Paxlovid and the company’s other patented vaccines and drugs.